Cargando…
Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
Introduction: Diabetic retinopathy (DR) is the leading cause of vision loss in the working age population of the developed world. DR encompasses a complex pathology, and one that is reflected in the variety of currently available treatments, which include laser photocoagulation, glucocorticoids, vit...
Autores principales: | Whitehead, Michael, Wickremasinghe, Sanjeewa, Osborne, Andrew, Van Wijngaarden, Peter, Martin, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299358/ https://www.ncbi.nlm.nih.gov/pubmed/30408422 http://dx.doi.org/10.1080/14712598.2018.1545836 |
Ejemplares similares
-
Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
por: Whitehead, Michael, et al.
Publicado: (2019) -
Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective
por: Bunch, Katharine L., et al.
Publicado: (2022) -
Pathophysiology of Diabetic Retinopathy
por: Tarr, Joanna M., et al.
Publicado: (2013) -
Diabetic Retinopathy: Pathophysiology and Treatments
por: Wang, Wei, et al.
Publicado: (2018) -
Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets
por: Nian, Shen, et al.
Publicado: (2021)